|
RNF169 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.016400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11319999999793E-05 |
| Normal-vs-Stage2 |
2.950000E-01 |
| Normal-vs-Stage3 |
5.323600E-02 |
| Normal-vs-Stage4 |
5.302000E-01 |
| Stage1-vs-Stage2 |
2.370800E-01 |
| Stage1-vs-Stage3 |
4.565000E-01 |
| Stage1-vs-Stage4 |
6.172800E-01 |
| Stage2-vs-Stage3 |
6.806400E-01 |
| Stage2-vs-Stage4 |
9.580000E-01 |
| Stage3-vs-Stage4 |
8.102400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.847600E-04 |
| Normal-vs-AfricanAmerican |
7.679300E-03 |
| Normal-vs-Asian |
6.171600E-04 |
| Caucasian-vs-AfricanAmerican |
9.868800E-01 |
| Caucasian-vs-Asian |
3.387000E-01 |
| AfricanAmerican-vs-Asian |
3.106800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35090000003202E-06 |
| Normal-vs-Female |
8.234200E-01 |
| Male-vs-Female |
1.761500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.420300E-02 |
| Normal-vs-Extreme_Weight |
1.16920000003962E-06 |
| Normal-vs-Obese |
1.080430E-01 |
| Normal-vs-Extreme_Obese |
3.759000E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.756040E-01 |
| Normal_Weight-vs-Obese |
4.068000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.900800E-01 |
| Extreme_Weight-vs-Obese |
1.012270E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.519800E-01 |
| Obese-vs-Extreme_Obese |
2.764000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.162400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.772200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.0256999999968E-05 |
| Normal-vs-Age(81-100Yrs) |
3.97979999999798E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.671000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.518200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.629700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.813500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.279920E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.743800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.91189999999764E-05 |
| Normal-VS-Type2 PRCC |
2.029900E-04 |
| Normal-VS-KIRP CIMP |
4.998000E-01 |
| Normal-VS-Unclassified PRCC |
8.506600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.617000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.464700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.663800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.135930E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.956100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.792600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41559999999874E-06 |
| Normal-vs-N1 |
9.959400E-01 |
| Normal-vs-N2 |
7.314200E-01 |
| N0-vs-N1 |
2.562400E-02 |
| N0-vs-N2 |
5.255800E-01 |
| N1-vs-N2 |
7.474600E-01 |
|
|
